US Patent Issued to OncoC4, Children's National Medical Center on Oct. 14 for "CD80 and CD86 binding protein compositions and uses thereof" (Maryland, District Of Columbia Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,780, issued on Oct. 14, was assigned to OncoC4 Inc. (Rockville, Md.) and Children's National Medical Center (Washington).

"CD80 and CD86 binding protein compositions and uses thereof" was invented by Yang Liu (Potomac, Md.), Pan Zheng (Potomac, Md.), Martin Devenport (Gaithersburg, Md.), Wei Wu (Washington), Xuexiang Du (Washington), Mingyue Liu (Washington) and Fei Tang (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to CTLA-4 protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy."

The patent was filed on Feb. 22, 2022, under Application No. 17/677,8...